New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
January 4, 2021 - Par launched an authorized brand alternative of Sucampo/Takeda’s Amitiza (lubiprostone) capsules.
Download PDF
Return to publications
